Lygature: result of the merger between CTMM and TI Pharma Since January 1 2016, CTMM (Center for Translational Molecular Medicine) and TI Pharma (Top Institute Pharma) are fully integrated into the new organization Lygature. Lygature was created to help preserve the expertise built up over many years, and to support new initiatives, including any arising from the Dutch government. Lygature is a not-for-profit organization, which drives the development of new medical solutions for patients by managing public-private partnerships involving academia, industry and society. Every day, Lygature brings together people in many different disciplines and organizations – to pioneer solutions in medical technology and pharmacotherapy, and to serve patients worldwide.